- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
7
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
7 companies
TTY Biopharm
Market Cap: NT$19.2b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$77.10
7D
1.3%
1Y
0.9%
Cenra
Market Cap: NT$5.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$35.25
7D
10.2%
1Y
1.6%
Allied Biotech
Market Cap: NT$2.3b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$23.45
7D
0.4%
1Y
34.0%
TSH Biopharm
Market Cap: NT$2.0b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.90
7D
-0.2%
1Y
9.3%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.8b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$30.05
7D
0.7%
1Y
-4.5%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$855.0m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$9.50
7D
5.1%
1Y
-19.1%
Bioray Biotech
Market Cap: NT$605.0m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$20.45
7D
17.2%
1Y
-25.8%